Department of Neurology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
School of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
Medicine (Baltimore). 2024 Oct 11;103(41):e40107. doi: 10.1097/MD.0000000000040107.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease caused by the neurogenic locus notch homolog protein 3 (NOTCH3) gene mutation. In recent years, most of the newly reported mutations of CADASIL patients mainly occur in exon 3 to 24, while the cases related to exon 2 mutation are rare, and clinical research data are relatively insufficient. In this study, we have reported a case of a rare heterozygous mutation c.128G>A (p.Cys43Tyr) in exon 2 of NOTCH3 in a 41-year-old Chinese man in the light of relevant literatures.
A 41-year-old man who suffered slurred speech for 5 days and right lower limb weakness for 4 days was admitted to our hospital.
Magnetic resonance imaging of the head revealed diffuse white matter lesions involving the outer capsular area and bilateral temporal poles. The rare heterozygous mutation c.128G>A (p.Cys43Tyr) in exon 2 of NOTCH3 was identified through molecular genetic testing. The proband was diagnosed as having CADASIL. Meanwhile, the same mutation was detected in 2 other family members III5 and IV9.
Atorvastatin calcium tablet (20 mg qd) and aspirin enteric-coated tablet (100 mg qd).
The patient was hospitalized for 3 weeks and discharged after his symptoms improved.
The heterozygous Cys43Tyr mutation in exon 2 of NOTCH3 is rare. Thus, our case report complements the rare mutation of exon 2 and offers additional clinical data for CADASIL patients.
脑常染色体显性动脉病伴皮质下梗死和白质脑病(CADASIL)是一种遗传性脑血管疾病,由神经源 Notch 同源蛋白 3(NOTCH3)基因突变引起。近年来,大多数新报道的 CADASIL 患者突变主要发生在外显子 3 到 24 ,而外显子 2 突变的病例较为罕见,临床研究数据相对不足。本研究结合相关文献报道了一例罕见的 NOTCH3 外显子 2 杂合突变 c.128G>A(p.Cys43Tyr)的病例。
一名 41 岁男性,因言语不清 5 天,右侧下肢无力 4 天入院。
头颅磁共振成像显示弥漫性白质病变,累及外囊区和双侧颞极。通过分子遗传学检测发现 NOTCH3 外显子 2 中罕见的杂合突变 c.128G>A(p.Cys43Tyr)。先证者被诊断为 CADASIL。同时,在另外 2 名家族成员 III5 和 IV9 中也检测到了相同的突变。
阿托伐他汀钙片(20 mg qd)和阿司匹林肠溶片(100 mg qd)。
患者住院 3 周后症状改善出院。
NOTCH3 外显子 2 的杂合 Cys43Tyr 突变较为罕见。因此,本病例报告补充了外显子 2 的罕见突变,为 CADASIL 患者提供了更多的临床数据。